Bath & Body Works Hits New 52-Week Low at $21.37

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 21.37 as of November 17, 2025. This marks a significant decline for the small-cap company, which operates within the footwear industry. Over the past year, Bath & Body Works has experienced a notable decrease in its stock value, with a performance drop of 52.99%, contrasting sharply with the S&P 500's gain of 13.19%.
The company's financial metrics reveal a challenging landscape. With a market capitalization of USD 6,299 million, Bath & Body Works has a price-to-earnings (P/E) ratio of 7.00, indicating a low valuation relative to earnings. However, the company faces hurdles with a negative book value and a return on equity that is significantly low. Additionally, net sales have contracted at an annual rate of -8.28% over the past five years, while operating profit has shown minimal growth.

The stock's performance has consistently lagged behind the S&P 500 over the last three years, reflecting ongoing difficulties in achieving sustainable growth. As Bath & Body Works navigates this challenging environment, its recent price movement underscores the need for strategic reassessment.